Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients
Tóm tắt
Từ khóa
Tài liệu tham khảo
Al-Lamki, 2015, TNF receptors: signaling pathways and contribution to renal dysfunction, Kidney Int, 87, 281, 10.1038/ki.2014.285
Palladino, 2003, Anti-TNF-alpha therapies: the next generation, Nat Rev Drug Discov, 2, 736, 10.1038/nrd1175
Fishman, 2007, Infection in solid-organ transplant recipients, N Engl J Med, 357, 2601, 10.1056/NEJMra064928
Nanau, 2014, Safety of anti-tumor necrosis factor therapies in arthritis patients, J Pharm Pharm Sci, 17, 324, 10.18433/J3WP4F
AlBugami, 2014, Malignancies: pre and post transplantation strategies, Transplant Rev (Orlando, 28, 76, 10.1016/j.trre.2013.12.002
Pena-Sagredo, 2008, Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience, Clin Exp Rheumatol, 26, 854
Lanternier, 2013, Incidence and risk factors of Legionella pneumophila pneumonia during anti-tumor necrosis factor therapy: a prospective French study, Chest, 144, 990, 10.1378/chest.12-2820
Winthrop, 2013, Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster, JAMA, 309, 887, 10.1001/jama.2013.1099
Winthrop, 2013, Mycobacterial diseases and antitumour necrosis factor therapy in USA, Ann Rheum Dis, 72, 37, 10.1136/annrheumdis-2011-200690
Salmon-Ceron, 2011, Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry, Ann Rheum Dis, 70, 616, 10.1136/ard.2010.137422
Lebrec, 2015, Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk, Curr Med Res Opin, 31, 557, 10.1185/03007995.2015.1011778
Sandhu, 2012, The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series, Aliment Pharmacol Ther, 36, 159, 10.1111/j.1365-2036.2012.05141.x
El-Nachef, 2010, Anti-tumor necrosis factor therapy for inflammatory bowel disease in the setting of immunosuppression for solid organ transplantation, Am J Gastroenterol, 105, 1210, 10.1038/ajg.2010.33
Schnitzler, 2015, Solid organ transplantation in patients with inflammatory bowel diseases (IBD): analysis of transplantation outcome and IBD activity in a large single center cohort, PLoS One, 10, e0135807, 10.1371/journal.pone.0135807
Temme, 2010, Infliximab as therapeutic option in steroid-refractory ulcerative colitis after kidney transplantation: case report, Transplant Proc, 42, 3880, 10.1016/j.transproceed.2010.08.044
Hoover, 2007, Etanercept therapy for severe plaque psoriasis in a patient who underwent a liver transplant, Cutis, 80, 211
Mohabbat, 2012, Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients, Aliment Pharmacol Ther, 36, 569, 10.1111/j.1365-2036.2012.05217.x
Leroy, 2009, Successful anti-TNFalpha treatment in a child with posttransplant recurrent focal segmental glomerulosclerosis, Am J Transplant, 9, 858, 10.1111/j.1600-6143.2009.02550.x
Solez, 2008, Banff 07 classification of renal allograft pathology: updates and future directions, Am J Transplant, 8, 753, 10.1111/j.1600-6143.2008.02159.x
Lal, 2007, Infliximab for ulcerative colitis following liver transplantation, Eur J Gastroenterol Hepatol, 19, 277, 10.1097/MEG.0b013e3280116ccc
Page, 2008, Tumor necrosis factor-alpha inhibitor-induced lupus-like syndrome presenting as fever of unknown origin in a liver transplant recipient: case report and concise review of the literature, Transplant Proc, 40, 1768, 10.1016/j.transproceed.2008.03.102
Indriolo, 2013, Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation, Aliment Pharmacol Ther, 37, 840, 10.1111/apt.12256
Brokalaki, 2012, Treatment of severe psoriasis with etanercept in a pancreas-kidney transplant recipient, Transplant Proc, 44, 2776, 10.1016/j.transproceed.2012.09.008
Collazo, 2008, Etanercept therapy for psoriasis in a patient with concomitant hepatitis C and liver transplant, P R Health Sci J, 27, 346
Madankumar, 2015, Use of etanercept for psoriasis in a liver transplant recipient, JAAD Case Rep, 1, S36, 10.1016/j.jdcr.2015.09.012
Metyas, 2007, The use of the tumour necrosis factor antagonist infliximab in heart transplant recipients: two case reports, Ann Rheum Dis, 66, 1544, 10.1136/ard.2007.070383
Arnott, 2003, Azathioprine and anti-TNF alpha therapies in Crohn's disease: a review of pharmacology, clinical efficacy and safety, Pharmacol Res, 47, 1, 10.1016/S1043-6618(02)00264-5
Schreiber, 2001, Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001–2003, Int J Colorectal Dis, 16, 1, 10.1007/s003840100285
Long, 2012, Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease, Gastroenterology, 143, 390.e1, 10.1053/j.gastro.2012.05.004
Beaugerie, 2009, Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study, Lancet, 374, 1617, 10.1016/S0140-6736(09)61302-7
Magro, 2014, Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III), J Crohns Colitis, 8, 31, 10.1016/j.crohns.2013.04.006
Soderlund, 2009, Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease, Gastroenterology, 136, 1561, 10.1053/j.gastro.2009.01.064
Castano-Milla, 2014, Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis, Aliment Pharmacol Ther, 39, 645, 10.1111/apt.12651
Baecklund, 2006, Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis, Arthritis Rheum, 54, 692, 10.1002/art.21675
Bongartz, 2006, Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials, JAMA, 295, 2275, 10.1001/jama.295.19.2275
Amari, 2011, Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis, Rheumatology (Oxford, 50, 1431, 10.1093/rheumatology/ker113
Williams, 2014, Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-alpha therapy in inflammatory bowel disease, Aliment Pharmacol Ther, 39, 447, 10.1111/apt.12624
Peyrin-Biroulet, 2011, Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease, Gastroenterology, 141, 1621.e1, 10.1053/j.gastro.2011.06.050
Baars, 2011, The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study, Am J Gastroenterol, 106, 319, 10.1038/ajg.2010.428
Scott, 2016, Risk of nonmelanoma skin cancer associated with the use of immunosuppressant and biologic agents in patients with a history of autoimmune disease and nonmelanoma skin cancer, JAMA Dermatol, 152, 164, 10.1001/jamadermatol.2015.3029
Raaschou, 2013, Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden, BMJ, 346, f1939, 10.1136/bmj.f1939
Penn, 1993, The effect of immunosuppression on pre-existing cancers, Transplantation, 55, 742, 10.1097/00007890-199304000-00011
Bernheim, 2015, Previous cancer/lymphoma and refractory inflammatory bowel disease, Dig Dis, 33, 44, 10.1159/000437064
Axelrad, 2016, Risk of new or recurrent cancer in patients with inflammatory bowel disease and previous cancer exposed to immunosuppressive and anti-tumor necrosis factor agents, Clin Gastroenterol Hepatol, 14, 58, 10.1016/j.cgh.2015.07.037
Imagawa, 1991, The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection, Transplantation, 51, 57, 10.1097/00007890-199101000-00008
Korsten, 2010, Drug-induced granulomatous interstitial nephritis in a patient with ankylosing spondylitis during therapy with adalimumab, Am J Kidney Dis, 56, e17, 10.1053/j.ajkd.2010.08.019
Yoshioka, 2013, [Granulomatous interstitial nephritis in a patient with Behcet's disease treated with infliximab], Nihon Jinzo Gakkai Shi, 55, 1412
Williams, 2011, TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists, Int J Dermatol, 50, 619, 10.1111/j.1365-4632.2011.04871.x
Shakoor, 2002, Drug-induced systemic lupus erythematosus associated with etanercept therapy, Lancet, 359, 579, 10.1016/S0140-6736(02)07714-0
Stokes, 2005, Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis, Nephrol Dial Transplant, 20, 1400, 10.1093/ndt/gfh832
Lahiri, 2015, Risk of infection with biologic antirheumatic therapies in patients with rheumatoid arthritis, Best Pract Res Clin Rheumatol, 29, 290, 10.1016/j.berh.2015.05.009